VANGUARD GROUP INC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 1 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$398,896
-18.1%
1,015,0040.0%0.00%
Q4 2022$487,202
-71.1%
1,015,004
+0.5%
0.00%
Q3 2022$1,686,000
-41.2%
1,010,1340.0%0.00%
Q2 2022$2,868,000
-28.2%
1,010,134
+27.2%
0.00%
Q1 2022$3,994,000
-49.7%
794,299
-0.3%
0.00%
Q4 2021$7,946,000
+245.3%
796,948
+350.4%
0.00%
Q3 2021$2,301,000
-6.4%
176,929
+1.2%
0.00%
Q2 2021$2,459,000
+335.2%
174,795
+399.4%
0.00%
Q1 2021$565,00035,0000.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRB Advisors LP 550,000$7,739,0001.75%
Bleichroeder LP 810,416$11,403,0001.72%
Aperture Investors, LLC 319,122$4,490,0000.51%
Ikarian Capital, LLC 325,000$4,573,0000.37%
SECTORAL ASSET MANAGEMENT INC 300,399$4,227,0000.34%
Baupost Group 1,208,159$16,693,0000.14%
Proficio Capital Partners LLC 112,059$1,577,0000.12%
LIGHT STREET CAPITAL MANAGEMENT, LLC 168,330$2,368,0000.10%
MSD Partners, L.P. 235,294$3,311,0000.09%
PURA VIDA INVESTMENTS, LLC 71,552$1,007,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders